Substituted isoindolinones
US11352338B2 · kind B2 · utility
0Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2020 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jun 25, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted isoindolinones of Formula (I), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat or ameliorate diseases, disorders, or conditions associated with protein malfunction, such as cancer, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.